dbacp07506
General Description
Peptide name : Brevinin-1HY
Source/Organism : Analogue of Brevinin-1H
Linear/Cyclic : Linear
Chirality : L
Sequence Information
Sequence : FALGAVTKVLYKLFCLITRKC
Peptide length: 21
C-terminal modification: Linear
N-terminal modification : Free
Non-natural peptide information:
Activity Information
Assay type : MTT assay
Assay time : 24-h
Activity : IC50 = 2.243 µM
Cell line : MDA-MB-435S
Cancer type : Breast Cancer
Other activity : Antimicrobial
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 2387.9894 Dalton
Aliphatic index : 1.3
Instability index : 2.5238
Hydrophobicity (GRAVY) : 1.0952
Isoelectric point : 9.6995
Charge (pH 7) : 3.7363
Aromaticity : 14.28
Molar extinction coefficient (cysteine, cystine): (2, 1)
Hydrophobic/hydrophilic ratio : 2
hydrophobic moment : -1.138
Missing amino acid : D,E,H,M,N,P,Q,S,W
Most occurring amino acid : L
Most occurring amino acid frequency : 4
Least occurring amino acid : G
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (42., 4.7, 57.)
SMILES Notation: CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHHHHHHHHHEEEHHHTTT |
| Chou-Fasman (CF) | CCEEEEEEECCCCEEEEECCC |
| Neural Network (NN) | HHHHHHHHHHHHHHHHHHCCC |
| Joint/Consensus | HHHHHHHHHHHHCEECCCCCC |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
CancerPPD : Not available
ApIAPDB : Not available
CancerPPD2 ID: 6701
Reference
1 : Pei X, et al. Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues. Chem Biol Drug Des. 2021; 97:273-282. doi: 10.1111/cbdd.13779
Literature
Paper title : Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.
Doi : https://doi.org/10.1111/cbdd.13779
Abstract : As drug-resistant bacteria have become a serious health problem and have caused thousands of deaths, finding new antibiotics has become an urgent research priority. A novel antimicrobial peptide, named Brevinin-1H, was identified in the skin secretion of Amolops hainanensis through 'shotgun' cloning. It has broad-spectrum antimicrobial activity against tested micro-organisms and has anticancer cell activity. To improve its bioactivity and decrease its cytotoxicity, two structural analogues-Brevinin-1Ha and Brevinin-1HY-were designed based on the secondary structure of the natural peptide. Brevinin-1HY, in which tyrosine substituted Pro11 , had similar activity to the natural peptide against Gram-negative bacteria and cancer cells, but showed a dramatic increase in haemolytic activity and cytotoxicity at its minimum inhibitory concentration. Brevinin-1Ha, which transferred the Rana-box from the C-terminal to a central position, had significantly decreased haemolytic activity, but also in antimicrobial and anticancer activity. The present data suggest that increasing the proportion of α-helix structure in an AMP can increase its target micro-organism bioactivity to some extent.